PDC line Pharma

{
  "events": [
    {
      "kind": "zetel_transfer",
      "seat_type": "siege_social",
      "new_address": {
        "raw": "4000 Li\u00E8ge, rue Louvrex, 55/57",
        "city": "Li\u00E8ge",
        "region": "waals_gewest",
        "street": "rue Louvrex",
        "country": "BE",
        "postcode": "4000",
        "box_number": null,
        "street_number": "55/57",
        "locality_suffix": null
      },
      "old_address": {
        "raw": "Boulevard Patience et Beaujonc, 3/6 \u00E0 4000 LIEGE",
        "city": "Li\u00E8ge",
        "region": "waals_gewest",
        "street": "Boulevard Patience et Beaujonc",
        "country": "BE",
        "postcode": "4000",
        "box_number": null,
        "street_number": "3/6",
        "locality_suffix": null
      },
      "effective_date": "2025-10-22",
      "evidence_quote": "Par jugement du 22 octobre 2025, le Tribunal de l\u0027entreprise de Li\u00E8ge - division Li\u00E8ge a homologu\u00E9 le transfert du si\u00E8ge de la soci\u00E9t\u00E9 PDC LINE en liquidation au cabinet du liquidateur situ\u00E9 \u00E0 4000 Li\u00E8ge, rue Louvrex, 55/57.",
      "region_changed": false,
      "is_statute_change": false,
      "nationality_change": false,
      "old_address_source": "header_volledig_adres",
      "statute_clause_text": null,
      "statute_article_number": null,
      "effective_date_qualifier": "retroactive",
      "statutaire_vs_werkelijke": "statutaire",
      "linguistic_region_changed": false,
      "court_jurisdiction_changed": false,
      "effective_date_is_approximate": false
    }
  ],
  "notary": {
    "name": "Roman AYDOGDU",
    "firm_city": null,
    "firm_name": null,
    "office_city": "Li\u00E8ge",
    "is_associated": false
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2025-12-04",
    "filing_date": "2025-10-22",
    "act_kind_objet": "Objet de l\u0027acte: Transfert du si\u00E8ge social"
  },
  "decision": {
    "body": "notarieel_alleen",
    "date": "2025-11-13",
    "unanimous": false
  },
  "subject_company": {
    "kbo": "0657.842.221",
    "name_full": "PDC LINE PHARMA",
    "legal_form": "SA"
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Roman AYDOGDU",
    "org_rep_person_name": null,
    "person_role_at_subject": "liquidateur"
  },
  "co_filed_documents": [
    "jugement du Tribunal de l\u0027entreprise de Li\u00E8ge",
    "acte notari\u00E9 de transfert du si\u00E8ge social"
  ]
}

{
  "events": [
    {
      "kind": "zetel_transfer",
      "seat_type": "siege_social",
      "new_address": {
        "raw": "4000 Li\u00E8ge, rue Louvrex, 55/57",
        "city": "Li\u00E8ge",
        "region": "waals_gewest",
        "street": "rue Louvrex",
        "country": "BE",
        "postcode": "4000",
        "box_number": null,
        "street_number": "55/57",
        "locality_suffix": null
      },
      "old_address": null,
      "effective_date": null,
      "evidence_quote": "Par jugement du 22 octobre 2025, le Tribunal de l\u0027entreprise de Li\u00E8ge - division Li\u00E8ge a homologu\u00E9 le transfert du si\u00E8ge de la soci\u00E9t\u00E9 PDC LINE en liquidation au cabinet du liquidateur situ\u00E9 \u00E0 4000 Li\u00E8ge, rue Louvrex, 55/57.",
      "region_changed": false,
      "is_statute_change": true,
      "nationality_change": false,
      "old_address_source": "inferred",
      "statute_clause_text": null,
      "statute_article_number": null,
      "effective_date_qualifier": null,
      "statutaire_vs_werkelijke": null,
      "linguistic_region_changed": false,
      "court_jurisdiction_changed": false,
      "effective_date_is_approximate": null
    }
  ],
  "notary": {
    "name": null,
    "firm_city": null,
    "firm_name": null,
    "office_city": null,
    "is_associated": false
  },
  "act_meta": {
    "language": "mixed",
    "pub_date": "2025-12-04",
    "filing_date": "2025-10-22",
    "act_kind_objet": "Objet de l\u0027acte:"
  },
  "decision": {
    "body": "buitengewone_algemene_vergadering",
    "date": "2025-10-22",
    "unanimous": null
  },
  "subject_company": {
    "kbo": "0657.842.221",
    "name_full": "PDC LINE PHARMA",
    "legal_form": "SA",
    "_kbo_filled_from_list": true
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Roman AYDOGDU",
    "org_rep_person_name": null,
    "person_role_at_subject": "liquidateur"
  },
  "co_filed_documents": []
}

{
  "events": [
    {
      "kind": "zetel_transfer",
      "seat_type": "statutaire",
      "new_address": {
        "city": "LIEGE",
        "region": "Brussels Gewest",
        "street": "Boulevard Patience et Beaujonc",
        "country": "BE",
        "postcode": "4000",
        "box_number": "6",
        "street_number": "3"
      },
      "old_address": {
        "city": "Li\u00E8ge",
        "region": "Waals",
        "street": "rue Louvrex",
        "country": "BE",
        "postcode": "4000",
        "box_number": "57",
        "street_number": "55"
      },
      "effective_date": "2025-10-22",
      "evidence_quote": "Par jugement du 22 octobre 2025, le Tribunal de l\u0027entreprise de Li\u00E8ge - division Li\u00E8ge a homologu\u00E9 le transfert du si\u00E8ge de la soci\u00E9t\u00E9 PDC LINE en liquidation au cabinet du liquidateur situ\u00E9 \u00E0 4000 Li\u00E8ge, rue Louvrex, 55/57."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0657.842.221",
    "name_full": "PDC LINE PHARMA",
    "legal_form": "SA"
  }
}

{
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "end_event": {
    "sub_type": "voluntary_dissolution_open",
    "liquidator": {
      "name": "Ma\u00EEtre Romari Aydogdu"
    }
  },
  "subject_company": {
    "kbo": "0657.842.221",
    "name_full": "PDC line Pharma"
  }
}

{
  "events": [
    {
      "kind": "director_in",
      "role": "vereffenaar",
      "person": {
        "rrn": null,
        "name": "Ma\u00EEtre Romany AYDOGDU",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2025-06-30",
      "evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale d\u00E9cide de nommer en tant que liquidateur pour une dur\u00E9e ind\u00E9termin\u00E9e: Ma\u00EEtre Romany AYDOGDU, avocat associ\u00E9 au sein du cabinet MOSAL, \u00E9tabli \u00E0 4000 Li\u00E8ge, Rue Louvrex 55."
    },
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "administrateurs en fonction",
        "address": null,
        "birth_date": null
      },
      "evidence_quote": "La dissolution met fin de plein droit aux mandats des administrateurs en fonction. L\u0027assembl\u00E9e g\u00E9n\u00E9rale leur donne d\u00E9charge pour l\u0027exercice de leur mandat pendant l\u0027exercice social en cours, mais sous r\u00E9serve de ce qui pourrait appara\u00EEtre du rapport du liquidateur, comme pouvant \u00EAtre mis \u00E0 leur char",
      "discharge_granted": true
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0657.842.221",
    "name_full": "PDC LINE PHARMA",
    "legal_form": "SA"
  }
}

{
  "notary": {
    "name": "Dimitri CLEENEWERCK",
    "firm_city": null,
    "firm_name": null,
    "office_city": "Bruxelles",
    "is_associated": false
  },
  "auditor": {
    "kind": "bedrijfsrevisor",
    "firm_kbo": null,
    "firm_name": "PwC Reviseurs d\u0027Entreprises SRL",
    "conclusion": "no_reserve",
    "ibr_number": null,
    "person_name": "Patrick Mortroux"
  },
  "act_meta": {
    "language": "mixed",
    "pub_date": "2025-08-26",
    "filing_date": "2025-03-31",
    "act_kind_objet": "Proc\u00E9dure de sonnette d\u0027alarme-Dissolution et mise en liquidation de la soci\u00E9t\u00E9-Nomination d\u0027un liquidateur-Pouvoirs du liquidateur-D\u00E9charge des administrateurs"
  },
  "decision": {
    "body": "buitengewone_algemene_vergadering",
    "act_date": "2025-06-30",
    "unanimous": true
  },
  "end_event": {
    "reason": "absence de financement suffisant",
    "art_wvv": [
      "2:71",
      "2:77",
      "2:78",
      "2:88"
    ],
    "is_death": true,
    "sub_type": "voluntary_dissolution_with_close",
    "critic_note": null,
    "closure_effective_date": "2025-06-30",
    "dissolution_effective_date": "2025-06-30",
    "liquidator_dropped_by_guard": null,
    "closure_effective_date_is_approximate": false,
    "dissolution_effective_date_is_approximate": false
  },
  "liquidator": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_dob": null,
    "person_rrn": null,
    "is_judicial": false,
    "person_name": "Romar\u0131 AYDOGDU",
    "is_remunerated": true,
    "person_address": "Rue Louvrex 55, 4000 Li\u00E8ge",
    "person_birth_place": null
  },
  "silent_merger": null,
  "court_division": {
    "name": "TRIBURAL DE L\u0027INTREPRISE DE LIEGE",
    "language": "fr",
    "tribunal_type": "entreprise"
  },
  "books_custodian": null,
  "subject_company": {
    "kbo": "0657.842.221",
    "name_full": "PDC line Pharma",
    "legal_form": "SA"
  },
  "closure_mandatary": {
    "kbo": null,
    "name": "Sibylle FALLA",
    "role": "notary"
  },
  "prior_opening_ref": null,
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Sibylle FALLA",
    "org_rep_person_name": null
  },
  "co_filed_documents": [
    "exp\u00E9dition conforme de l\u0027acte",
    "liste de pr\u00E9sence",
    "homologation du tribunal de l\u0027entreprise de Li\u00E8ge"
  ],
  "real_estate_transferred": [],
  "shareholder_loan_settled": null,
  "financials_at_dissolution": {
    "equity_eur": null,
    "reported_at": "2025-03-31",
    "net_equity_sign": "negative",
    "continuity_basis": "discontinuity",
    "net_position_eur": -7703912.0,
    "balance_total_eur": 2430372.0
  },
  "distribution_to_shareholders": null
}

{
  "events": [
    {
      "date": "2025-06-30",
      "kind": "ontbinding",
      "liquidators": [
        {
          "name": "Ma\u00EEtre Roman AYDOGDU",
          "role": "vereffenaar"
        }
      ],
      "evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale d\u00E9cide la dissolution de la soci\u00E9t\u00E9, qui n\u0027existera plus en cons\u00E9quence que pour les besoins de sa liquidation, et prononce sa mise en liquidation \u00E0 compter du jour de l\u0027acte."
    },
    {
      "date": "2025-06-30",
      "kind": "invereffeningstelling",
      "liquidators": [
        {
          "name": "Ma\u00EEtre Roman AYDOGDU",
          "role": "vereffenaar"
        }
      ],
      "evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale d\u00E9cide la dissolution de la soci\u00E9t\u00E9, qui n\u0027existera plus en cons\u00E9quence que pour les besoins de sa liquidation, et prononce sa mise en liquidation \u00E0 compter du jour de l\u0027acte."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "final_status": "in_vereffening",
  "subject_company": {
    "kbo": "0657.842.221"
  }
}

{
  "events": [
    {
      "kind": "commissaris_in",
      "role": "commissaris",
      "person": null,
      "reason": null,
      "subkind": "additional",
      "via_org": {
        "kbo": null,
        "name": "PwC Reviseurs d\u0027Entreprises SRL",
        "address": null,
        "country": "BE",
        "legal_form": "SRL"
      },
      "statutory": null,
      "compensated": null,
      "effective_date": "2025-06-17",
      "evidence_quote": "Conform\u00E9ment \u00E0 l\u0027article 2:71 \u00A72 du Code des soci\u00E9t\u00E9s et des associations, nous vous pr\u00E9sentons notre rapport \u00E0 l\u0027assembl\u00E9e g\u00E9n\u00E9rale extraordinaire en notre qualit\u00E9 de commissaire, pour laquelle nous avons \u00E9t\u00E9 d\u00E9sign\u00E9s par lettre de mission du 3 juin 2025",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "decharge_granted",
      "role": "administrateur",
      "person": null,
      "reason": null,
      "subkind": null,
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale leur donne d\u00E9charge pour l\u0027exercice de leur mandat pendant l\u0027exercice social en cours, mais sous r\u00E9serve de ce qui pourrait appara\u00EEtre du rapport du liquidateur, comme pouvant \u00EAtre mis \u00E0 leur charge.",
      "decharge_status": "provisional",
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    }
  ],
  "notary": {
    "name": "Dimitri CLEENEWERCK de CRAYENCOUR",
    "firm_city": null,
    "firm_name": null,
    "office_city": "Bruxelles",
    "is_associated": false
  },
  "act_meta": {
    "language": "mixed",
    "pub_date": "2025-08-26",
    "filing_date": "2025-03-31",
    "act_kind_objet": "Objet de l\u0027acte:"
  },
  "decisions": [
    {
      "body": "algemene_vergadering",
      "date": "2025-07-09",
      "unanimous": true
    },
    {
      "body": "algemene_vergadering",
      "date": "2025-07-09",
      "unanimous": true
    },
    {
      "body": "algemene_vergadering",
      "date": "2025-07-09",
      "unanimous": true
    },
    {
      "body": "algemene_vergadering",
      "date": "2025-07-09",
      "unanimous": true
    },
    {
      "body": "algemene_vergadering",
      "date": "2025-07-09",
      "unanimous": true
    },
    {
      "body": "algemene_vergadering",
      "date": "2025-07-09",
      "unanimous": true
    },
    {
      "body": "algemene_vergadering",
      "date": "2025-07-09",
      "unanimous": true
    },
    {
      "body": "algemene_vergadering",
      "date": "2025-07-09",
      "unanimous": true
    }
  ],
  "is_correction": false,
  "subject_company": {
    "kbo": "0657.842.221",
    "name_full": "PDC line Pharma",
    "legal_form": "SA"
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Sibylle FALLA",
    "org_rep_person_name": null,
    "person_role_at_subject": "Notaire associ\u00E9"
  },
  "co_filed_documents": [
    "exp\u00E9dition conforme de l\u0027acte",
    "liste de pr\u00E9sence",
    "homologation du tribunal de l\u0027entreprise de Li\u00E8ge"
  ],
  "corrected_publication_numac": null
}

{
  "events": [
    {
      "kind": "director_in",
      "role": "liquidateur",
      "person": {
        "rrn": null,
        "name": "Ma\u00EEtre Romari Aydogdu",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0657.842.221",
    "name_full": "PDC line Pharma"
  }
}

{
  "events": [
    {
      "kind": "director_out",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Patrick STRAGIER",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Marleen LIMBOURG",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0657.842.221",
    "name_full": "PDC LINE PHARMA"
  }
}

{
  "events": [
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Patrick STRAGIER",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": "0657842221",
        "name": "S.R.L. NOSHAQ PARTNERS",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "evidence_quote": "Par un courrier du 17 mai 2024 adress\u00E9 au Conseil d\u0027administration de la S.A. PDC LINE PHARMA, la S.R.L. NOSHAQ PARTNERS a inform\u00E9 la soci\u00E9t\u00E9 du remplacement de son repr\u00E9sentant permanent, MadMonsieur Patrick STRAGIER, par Madame Marleen LIMBOURG, avec effet imm\u00E9diat."
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Marleen LIMBOURG",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": "0657842221",
        "name": "S.R.L. NOSHAQ PARTNERS",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "evidence_quote": "Par un courrier du 17 mai 2024 adress\u00E9 au Conseil d\u0027administration de la S.A. PDC LINE PHARMA, la S.R.L. NOSHAQ PARTNERS a inform\u00E9 la soci\u00E9t\u00E9 du remplacement de son repr\u00E9sentant permanent, MadMonsieur Patrick STRAGIER, par Madame Marleen LIMBOURG, avec effet imm\u00E9diat."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0657.842.221",
    "name_full": "PDC LINE PHARMA",
    "legal_form": "SA"
  }
}

{
  "events": [
    {
      "kind": "commissaris_out",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "Patrick STRAGIER",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "commissaris_in",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "Marleen LIMBOURG",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": "Patrick STRAGIER",
      "effective_date_qualifier": "immediate"
    }
  ],
  "notary": {
    "name": null,
    "firm_city": null,
    "firm_name": null,
    "office_city": "LIEGE",
    "is_associated": false
  },
  "act_meta": {
    "language": "mixed",
    "pub_date": "2024-06-21",
    "filing_date": "2024-05-17",
    "act_kind_objet": "D\u00E9mission- Nomination"
  },
  "decisions": [
    {
      "body": "enig_aandeelhouder_schriftelijk",
      "date": "2024-05-17",
      "unanimous": null
    }
  ],
  "is_correction": false,
  "subject_company": {
    "kbo": "0657.842.221",
    "name_full": "PDC LINE PHARMA",
    "legal_form": "S.A."
  },
  "publication_proxy": {
    "kind": "org",
    "org_kbo": null,
    "org_name": "NOSHAQ",
    "person_name": null,
    "org_rep_person_name": "St\u00E9phanie CRAHAY",
    "person_role_at_subject": null
  },
  "co_filed_documents": [],
  "corrected_publication_numac": null
}

{
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "statute_change": {
    "name_change": false,
    "seat_change": false,
    "object_change": false,
    "effective_date": "2023-12-15",
    "legal_form_change": false
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0657.842.221",
    "name_full": "PDC LINE PHARMA",
    "legal_form": "SA"
  },
  "signature_regime": null,
  "special_mandates": [
    {
      "quote": "au notaire soussign\u00E9 aux fins de proc\u00E9der \u00E0 la publication du pr\u00E9sent proc\u00E8s-verbal aux Annexes du Moniteur belge et pour l\u2019\u00E9tablissement d\u2019une version coordonn\u00E9e des statuts. A ces fins, chaque mandataire pourra au nom de la soci\u00E9t\u00E9, faire toutes d\u00E9clarations, signer tous documents et pi\u00E8ces et, en g\u00E9n\u00E9ral, faire le n\u00E9cessaire.",
      "holder_kbo": null,
      "holder_name": "Ma\u00EEtre G\u00E9rard INDEKEU",
      "scope_categories": [
        "publication",
        "filing"
      ],
      "with_substitution": true
    }
  ],
  "governance_change": {
    "admin_delegated_added": []
  }
}

{
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "name_change": {
    "new": "",
    "old": "",
    "changed": false
  },
  "seat_change": {
    "changed": false
  },
  "object_change": {
    "changed": false
  },
  "subject_company": {
    "kbo": "0657.842.221",
    "name_full": "PDC line Pharma"
  },
  "legal_form_change": {
    "new": "Soci\u00E9t\u00E9 anonyme",
    "old": "Soci\u00E9t\u00E9 anonyme",
    "changed": false
  }
}

{
  "stage": null,
  "notary": {
    "name": "G\u00E9rard INDEKEU",
    "firm_city": null,
    "firm_name": null,
    "office_city": "Bruxelles",
    "is_associated": false
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2024-01-11",
    "filing_date": "2024-01-09",
    "act_kind_objet": "DIVERS"
  },
  "decision": {
    "body": "buitengewone_algemene_vergadering",
    "act_date": "2023-09-08",
    "unanimous": true
  },
  "conversion": null,
  "detected_kind": "other",
  "report_waiver": null,
  "restructuring": {
    "parties": [
      {
        "kbo": "0657.842.221",
        "name": "PDC line Pharma",
        "role": "other",
        "address": "Boulevard de Patience et Beaujonc 3 bte 6, 4000 Li\u00E8ge",
        "is_foreign": false,
        "legal_form": "Soci\u00E9t\u00E9 anonyme",
        "is_new_company": false,
        "jurisdiction_country": "BE"
      }
    ],
    "exchange_ratio": null,
    "legal_articles": [],
    "is_cross_border": false,
    "is_silent_merger": false,
    "balance_basis_date": "2022-12-31",
    "exchange_ratio_text": null,
    "new_shares_issued_n": null,
    "real_estate_included": false,
    "patrimony_description": "La r\u00E9duction du compte \u0027Primes d\u0027\u00E9mission\u0027 est effectu\u00E9e par apurement des pertes report\u00E9es, conform\u00E9ment aux comptes annuels cl\u00F4tur\u00E9s le 31 d\u00E9cembre 2022.",
    "equity_transferred_eur": null,
    "accounting_effective_date": null
  },
  "subject_company": {
    "kbo": "0657.842.221",
    "name_full": "PDC line Pharma",
    "legal_form": "Soci\u00E9t\u00E9 anonyme"
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "G\u00E9rard INDEKEU",
    "org_rep_person_name": null
  },
  "summary_narrative": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale extraordinaire des actionnaires de PDC line Pharma, soci\u00E9t\u00E9 anonyme inscrite au registre des personnes morales sous le num\u00E9ro 0657.842.221, s\u0027est tenue le 8 septembre 2023. \u00C0 l\u0027unanimit\u00E9, elle a d\u00E9cid\u00E9 de r\u00E9duire le compte \u00AB Primes d\u0027\u00E9mission \u00BB de 24.124.133,00 \u20AC \u00E0 4.999.029,91 \u20AC par apurement des pertes report\u00E9es, telles qu\u0027elles figurent dans les comptes annuels cl\u00F4tur\u00E9s le 31 d\u00E9cembre 2022. L\u0027assembl\u00E9e a \u00E9galement attribu\u00E9 tous pouvoirs \u00E0 l\u0027administrateur-d\u00E9l\u00E9gu\u00E9 et au notaire pour les d\u00E9marches administratives et la publication du proc\u00E8s-verbal.",
  "co_filed_documents": [
    "exp\u00E9dition conforme de l\u0027acte",
    "liste de pr\u00E9sences"
  ],
  "detected_real_type": "other",
  "referenced_correction": null,
  "should_reroute_to_category": "statutes"
}

{
  "stage": null,
  "notary": {
    "name": "G\u00E9rard INDEKEU",
    "firm_city": null,
    "firm_name": null,
    "office_city": "Bruxelles",
    "is_associated": false
  },
  "act_meta": {
    "language": "nl",
    "pub_date": "2024-01-11",
    "filing_date": "2024-01-09",
    "act_kind_objet": "DIVERS"
  },
  "decision": {
    "body": "algemene_vergadering",
    "act_date": "2023-09-08",
    "unanimous": true
  },
  "conversion": null,
  "detected_kind": "other",
  "report_waiver": null,
  "restructuring": {
    "parties": [
      {
        "kbo": "0657.842.221",
        "name": "PDC line Pharma",
        "role": "other",
        "address": "Boulevard de Patience et Beaujonc 3 bte 6 : 4000 Li\u00E8ge",
        "is_foreign": false,
        "legal_form": "Soci\u00E9t\u00E9 anonyme",
        "is_new_company": false,
        "jurisdiction_country": null
      }
    ],
    "exchange_ratio": null,
    "legal_articles": [],
    "is_cross_border": false,
    "is_silent_merger": false,
    "balance_basis_date": "2022-12-31",
    "exchange_ratio_text": null,
    "new_shares_issued_n": null,
    "real_estate_included": false,
    "patrimony_description": null,
    "equity_transferred_eur": null,
    "accounting_effective_date": null
  },
  "subject_company": {
    "kbo": "0657.842.221",
    "name_full": "PDC line Pharma",
    "legal_form": "Soci\u00E9t\u00E9 anonyme"
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "G\u00E9ard INDEKEU",
    "org_rep_person_name": null
  },
  "summary_narrative": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale extraordinaire des actionnaires de la soci\u00E9t\u00E9 PDC line Pharma a pris \u00E0 l\u0027unanimit\u00E9 des r\u00E9solutions concernant la r\u00E9duction du compte prime d\u0027\u00E9mission et la d\u00E9l\u00E9gation de pouvoirs.",
  "co_filed_documents": [
    "exp\u00E9dition conforme de l\u0027acte",
    "liste de pr\u00E9sences",
    "procurations"
  ],
  "detected_real_type": "other",
  "referenced_correction": null,
  "should_reroute_to_category": "capital_shares"
}

{
  "events": [
    {
      "kind": "director_out",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Amel Tounsi",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Patrick Stragier",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0657.842.221",
    "name_full": "PDC LINE PHARMA"
  }
}

{
  "events": [
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "NOSHAQ PARTNERS",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2023-11-15",
      "evidence_quote": "la S.R.L. NOSHAQ PARTNERS a inform\u00E9 la soci\u00E9t\u00E9 du remplacement de son repr\u00E9sentant permanent, Madame Amel TOUNSI, par Monsieur Patrick STRAGIER, avec effet imm\u00E9diat."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0657.842.221",
    "name_full": "PDC LINE PHARMA",
    "legal_form": "SA"
  }
}

{
  "events": [
    {
      "kind": "commissaris_in",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "Patrick STRAGIER",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": "successor_conditional",
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "la S.R.L. NOSHAQ PARTNERS a inform\u00E9 la soci\u00E9t\u00E9 du remplacement de son repr\u00E9sentant permanent, Madame Amel TOUNSI, par Monsieur Patrick STRAGIER, avec effet imm\u00E9diat.",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": "Patrick STRAGIER",
      "rep_rotation_old_rep": "Amel TOUNSI",
      "effective_date_qualifier": "immediate"
    },
    {
      "kind": "decharge_granted",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "Amel TOUNSI",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "",
      "decharge_status": "granted",
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    }
  ],
  "notary": {
    "name": null,
    "firm_city": null,
    "firm_name": null,
    "office_city": "LIEGE",
    "is_associated": false
  },
  "act_meta": {
    "language": "mixed",
    "pub_date": "2023-12-14",
    "filing_date": "2023-12-01",
    "act_kind_objet": "Objet de l\u0027acte:"
  },
  "decisions": [
    {
      "body": "enig_aandeelhouder_schriftelijk",
      "date": "2023-11-15",
      "unanimous": null
    }
  ],
  "is_correction": false,
  "subject_company": {
    "kbo": "0657.842.221",
    "name_full": "PDC LINE PHARMA",
    "legal_form": "S.A."
  },
  "publication_proxy": {
    "kind": "org",
    "org_kbo": null,
    "org_name": "S.A. NOSHAQ",
    "person_name": null,
    "org_rep_person_name": "St\u00E9phanie CRAHAY",
    "person_role_at_subject": null
  },
  "co_filed_documents": [],
  "corrected_publication_numac": null
}

{
  "events": [
    {
      "kind": "capital_decrease",
      "amount": 3237781.8,
      "currency": "EUR",
      "after_eur": 4000000.0,
      "delta_eur": -3237781.8,
      "before_eur": 7237781.8,
      "amount_type": "kapitaal_effectief",
      "effective_date": "2023-05-23",
      "evidence_quote": "L\u2019assembl\u00E9e g\u00E9n\u00E9rale d\u00E9cide de r\u00E9duire le capital \u00E0 concurrence de trois millions deux cent trente-sept mille sept cent quatre-vingt-un euros quatre-vingt cents (3.237.781,80 \u20AC) pour le porter de sept millions deux cent trente-sept mille sept cent quatre-vingt-un euros et quatre-vingt centimes (7.237.781,80 \u20AC) \u00E0 quatre millions d\u2019euros (4.000.000,00 \u20AC)",
      "contribution_type": null
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0657.842.221",
    "name_full": "PDC LINE PHARMA",
    "legal_form": "SA"
  }
}

{
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "name_change": {
    "new": "",
    "old": "",
    "changed": false
  },
  "seat_change": {
    "changed": false
  },
  "object_change": {
    "changed": false
  },
  "subject_company": {
    "kbo": "0657.842.221",
    "name_full": "PDC line Pharma"
  },
  "legal_form_change": {
    "new": "",
    "old": "Soci\u00E9t\u00E9 anonyme",
    "changed": false
  }
}

{
  "events": [
    {
      "kind": "capital_decrease",
      "after_eur": 4000000.0,
      "delta_eur": -3237781.8,
      "before_eur": 7237781.8,
      "contribution_type": null
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0657.842.221",
    "name_full": "PDC line Pharma"
  }
}

{
  "events": [
    {
      "kind": "capital_decrease",
      "after_eur": 4000000.0,
      "delta_eur": -3237781.8,
      "before_eur": 7237781.8,
      "decrease_purpose": "loss_absorption",
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "share_class_creation",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "share_emission": {
        "agio_eur": null,
        "share_form": "no_nominal_value",
        "share_class": null,
        "n_new_shares": 226898,
        "with_new_shares": true,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": null,
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    }
  ],
  "notary": {
    "name": "G\u00E9rard INDEKEU",
    "firm_city": null,
    "firm_name": null,
    "office_city": "Bruxelles",
    "is_associated": false
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2023-07-04",
    "filing_date": "2023-06-30",
    "act_kind_objet": "Objet de l\u0027acte:"
  },
  "decision": {
    "body": "assembl\u00E9e_generale_extraordinaire",
    "act_date": "2023-05-23",
    "unanimous": true,
    "under_authorized_capital": false,
    "underlying_resolution_date": "2023-05-23"
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0657.842.221",
    "name_full": "PDC line Pharma",
    "legal_form": "Soci\u00E9t\u00E9 anonyme",
    "is_foreign_registered": false
  },
  "publication_proxy": {
    "kind": "none",
    "org_kbo": null,
    "org_name": null,
    "person_name": null,
    "org_rep_person_name": null,
    "person_role_at_subject": null
  },
  "co_filed_documents": [
    "exp\u00E9dition conforme de l\u0027acte",
    "procurations",
    "statuts coordonn\u00E9s"
  ],
  "shareholders_after": [],
  "share_classes_after": [
    {
      "n_shares": 226898,
      "class_name": "A",
      "capital_share_eur": 4000000.0,
      "voting_rights_per_share": null
    },
    {
      "n_shares": 226898,
      "class_name": "B",
      "capital_share_eur": 4000000.0,
      "voting_rights_per_share": null
    },
    {
      "n_shares": 226898,
      "class_name": "C",
      "capital_share_eur": 4000000.0,
      "voting_rights_per_share": null
    },
    {
      "n_shares": 226898,
      "class_name": "D",
      "capital_share_eur": 4000000.0,
      "voting_rights_per_share": null
    },
    {
      "n_shares": 226898,
      "class_name": "E",
      "capital_share_eur": 4000000.0,
      "voting_rights_per_share": null
    }
  ]
}

{
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "statute_change": {
    "name_change": false,
    "seat_change": false,
    "object_change": false,
    "effective_date": "2023-05-23",
    "legal_form_change": false
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0657.842.221",
    "name_full": "PDC LINE PHARMA",
    "legal_form": "SA"
  },
  "signature_regime": null,
  "special_mandates": [],
  "governance_change": {
    "admin_delegated_added": []
  }
}

{
  "events": [
    {
      "kind": "zetel_transfer",
      "seat_type": "statutaire",
      "new_address": {
        "city": "Li\u00E8ge",
        "region": null,
        "street": "Boulevard Patience et Beaujonc",
        "country": "BE",
        "postcode": "4000",
        "box_number": "6",
        "street_number": "3"
      },
      "old_address": {
        "city": "Li\u00E8ge",
        "region": null,
        "street": "avenue de l\u0027H\u00F4pital",
        "country": "BE",
        "postcode": "4000",
        "box_number": "34",
        "street_number": "11"
      },
      "effective_date": "2023-07-01",
      "evidence_quote": "Les administrateurs d\u00E9cident de transf\u00E9rer le si\u00E8ge social de la Soci\u00E9t\u00E9 \u00E0 l\u0027adresse suivante, avec effet au 1er juillet 2023: Boulevard Patience et Beaujonc n\u00B03 bo\u00EEte 6 4000 Li\u00E8ge"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0657.842.221",
    "name_full": "PDC LINE PHARMA",
    "legal_form": "SA"
  }
}

{
  "events": [
    {
      "kind": "zetel_transfer",
      "seat_type": "siege_social",
      "new_address": {
        "raw": "Boulevard Patience et Beaujonc n\u00B03 bo\u00EEte 6\n4000 Li\u00E8ge",
        "city": "Li\u00E8ge",
        "region": "waals_gewest",
        "street": "Boulevard Patience et Beaujonc",
        "country": "BE",
        "postcode": "4000",
        "box_number": "6",
        "street_number": "3",
        "locality_suffix": null
      },
      "old_address": null,
      "effective_date": "2023-07-01",
      "evidence_quote": "Les administrateurs d\u00E9cident de transf\u00E9rer le si\u00E8ge social de la Soci\u00E9t\u00E9 \u00E0 l\u0027adresse suivante, avec effet au 1er juillet 2023:",
      "region_changed": false,
      "is_statute_change": true,
      "nationality_change": false,
      "old_address_source": "inferred",
      "statute_clause_text": null,
      "statute_article_number": null,
      "effective_date_qualifier": "absolute",
      "statutaire_vs_werkelijke": "statutaire",
      "linguistic_region_changed": false,
      "court_jurisdiction_changed": false,
      "effective_date_is_approximate": false
    }
  ],
  "notary": {
    "name": null,
    "firm_city": null,
    "firm_name": null,
    "office_city": null,
    "is_associated": false
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2023-06-09",
    "filing_date": "2023-06-01",
    "act_kind_objet": "Objet de l\u0027acte:"
  },
  "decision": {
    "body": "enig_aandeelhouder_schriftelijk",
    "date": "2023-05-09",
    "unanimous": null
  },
  "subject_company": {
    "kbo": "0657.842.221",
    "name_full": "PDC line Pharma",
    "legal_form": "SA"
  },
  "publication_proxy": {
    "kind": "org",
    "org_kbo": null,
    "org_name": "CarKath SRL",
    "person_name": null,
    "org_rep_person_name": "Eric Halioua",
    "person_role_at_subject": null
  },
  "co_filed_documents": [
    "Annexes du Moniteur belge"
  ]
}

{
  "events": [
    {
      "kind": "zetel_transfer",
      "seat_type": "siege_social",
      "new_address": {
        "raw": "Boulevard Patience et Beaujonc n\u00B03 bo\u00EEte 6, 4000 Li\u00E8ge",
        "city": "Li\u00E8ge",
        "region": "waals_gewest",
        "street": "Boulevard Patience et Beaujonc",
        "country": "BE",
        "postcode": "4000",
        "box_number": "6",
        "street_number": "3",
        "locality_suffix": null
      },
      "old_address": {
        "raw": "Tour GIGA b34, avenue de l\u0027H\u00F4pital, 11 \u00E0 4000 Li\u00E8ge",
        "city": "Li\u00E8ge",
        "region": "waals_gewest",
        "street": "avenue de l\u0027H\u00F4pital",
        "country": "BE",
        "postcode": "4000",
        "box_number": null,
        "street_number": "11",
        "locality_suffix": null
      },
      "effective_date": "2023-07-01",
      "evidence_quote": "Les administrateurs d\u00E9cident de transf\u00E9rer le si\u00E8ge social de la Soci\u00E9t\u00E9 \u00E0 l\u0027adresse suivante, avec effet au 1er juillet 2023: Boulevard Patience et Beaujonc n\u00B03 bo\u00EEte 6, 4000 Li\u00E8ge",
      "region_changed": false,
      "is_statute_change": false,
      "nationality_change": false,
      "old_address_source": "header_volledig_adres",
      "statute_clause_text": null,
      "statute_article_number": null,
      "effective_date_qualifier": "absolute",
      "statutaire_vs_werkelijke": "statutaire",
      "linguistic_region_changed": false,
      "court_jurisdiction_changed": false,
      "effective_date_is_approximate": false
    }
  ],
  "notary": {
    "name": "notary\u0027s full name (not specified in text)",
    "firm_city": null,
    "firm_name": null,
    "office_city": "Li\u00E8ge",
    "is_associated": false
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2023-06-09",
    "filing_date": "2023-06-01",
    "act_kind_objet": "Objet de l\u0027acte:"
  },
  "decision": {
    "body": "raad_van_bestuur",
    "date": "2023-05-09",
    "unanimous": true
  },
  "subject_company": {
    "kbo": "0657.842.221",
    "name_full": "PDC line Pharma",
    "legal_form": "SA"
  },
  "publication_proxy": {
    "kind": "org",
    "org_kbo": "0657.842.221",
    "org_name": "CarKath SRL",
    "person_name": null,
    "org_rep_person_name": "Eric Halioua",
    "person_role_at_subject": null
  },
  "co_filed_documents": [
    "Extrait des d\u00E9cisions \u00E9crites des administrateurs",
    "Proc\u00E8s-verbal de d\u00E9cision des administrateurs"
  ]
}

{
  "stage": null,
  "notary": {
    "name": "G\u00E9rard INDEKEU",
    "firm_city": null,
    "firm_name": null,
    "office_city": "Bruxelles",
    "is_associated": false
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2023-03-22",
    "filing_date": "2023-03-20",
    "act_kind_objet": "DIVERS"
  },
  "decision": {
    "body": "buitengewone_algemene_vergadering",
    "act_date": "2023-02-07",
    "unanimous": true
  },
  "conversion": null,
  "detected_kind": "other",
  "report_waiver": null,
  "restructuring": null,
  "subject_company": {
    "kbo": "0657.842.221",
    "name_full": "PDC line Pharma",
    "legal_form": "Soci\u00E9t\u00E9 anonyme"
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "G\u00E9rard INDEKEU",
    "org_rep_person_name": null
  },
  "summary_narrative": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale extraordinaire des actionnaires de PDC line Pharma, soci\u00E9t\u00E9 anonyme inscrite au registre des personnes morales sous le num\u00E9ro 0657.842.221, s\u0027est r\u00E9unie le 7 f\u00E9vrier 2023. \u00C0 l\u0027unanimit\u00E9, elle a confirm\u00E9 la prolongation de la dur\u00E9e des 11.450 droits de souscription attribu\u00E9s en 2019, les a red\u00E9finis en mati\u00E8re de b\u00E9n\u00E9ficiaires, Good Leaver et Bad Leaver, et a modifi\u00E9 les p\u00E9riodes de vesting et d\u0027exercice des options sur actions dans les plans SOP 2019, 2020 et 2021. Elle a \u00E9galement attribu\u00E9 des pouvoirs \u00E0 l\u0027administrateur-d\u00E9l\u00E9gu\u00E9 et au notaire pour les d\u00E9marches administra",
  "co_filed_documents": [
    "exp\u00E9dition conforme de l\u0027acte",
    "liste de pr\u00E9sences"
  ],
  "detected_real_type": "other",
  "referenced_correction": null,
  "should_reroute_to_category": "statutes"
}

{
  "events": [
    {
      "kind": "director_out",
      "role": "commissaire aux comptes",
      "person": {
        "rrn": null,
        "name": "L\u0026S R\u00E9viseurs d\u0027Entreprises SRL",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "commissaire aux comptes",
      "person": {
        "rrn": null,
        "name": "SCRL PwC Reviseurs d\u0027Entreprises",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0657.842.221",
    "name_full": "PDC line Pharma"
  }
}

{
  "events": [
    {
      "kind": "commissaris_out",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "Abdel Serghini",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": null,
        "name": "L\u0026S R\u00E9viseurs d\u0027Entreprises SRL",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "evidence_quote": "Par r\u00E9solution prise \u00E0 l\u0027unanimit\u00E9 lors de l\u0027Assembl\u00E9e G\u00E9n\u00E9rale du 19 mai 2022, il a \u00E9t\u00E9 pris acte de la d\u00E9mission de L\u0026S R\u00E9viseurs d\u0027Entreprises SRL, repr\u00E9sent\u00E9e par Abdel Serghini, r\u00E9viseur, de son mandat de Commissaire."
    },
    {
      "kind": "commissaris_in",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "Patrick Mortroux",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": null,
        "name": "SCRL PwC Reviseurs d\u0027Entreprises",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "evidence_quote": "L\u0027assembl\u00E9e a d\u00E9cid\u00E9 de nommer la SCRL PwC Reviseurs d\u0027Entreprises, repr\u00E9sent\u00E9e par Patrick Mortroux, r\u00E9viseur, en tant que nouveau Commissaire aux comptes;"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0657.842.221",
    "name_full": "PDC LINE PHARMA",
    "legal_form": "SA"
  }
}